Atrial natriuretic polypeptide as a novel antigrowth factor of endothelial cells.
about
Differential gene expression of the three natriuretic peptides and natriuretic peptide receptor subtypes in human liverRole of corin and atrial natriuretic peptide in preeclampsiaAtrial natriuretic peptide in cardiovascular biology and disease (NPPA)C-type natriuretic peptide receptor expression in pancreatic alpha cellsPressure-independent enhancement of cardiac hypertrophy in natriuretic peptide receptor A-deficient miceIdentification and functionality of proteomes secreted by rat cardiac stem cells and neonatal cardiomyocytesThe role of iNOS-derived NO in the antihypertrophic actions of B-type natriuretic peptide in neonatal rat cardiomyocytesCentral role of guanylyl cyclase in natriuretic peptide signaling in hypertension and metabolic syndrome.Functional interaction of NF-Y and Sp1 is required for type a natriuretic peptide receptor gene transcription.GREBP, a cGMP-response element-binding protein repressing the transcription of natriuretic peptide receptor 1 (NPR1/GCA).Endogenous vascular synthesis of B-type and C-type natriuretic peptides in the rainbow trout.ANP in regulation of arterial pressure and fluid-electrolyte balance: lessons from genetic mouse models.Cardiac natriuretic peptides--hope or hype?Autocrine and paracrine effects of atrial natriuretic peptide gene transfer on vascular smooth muscle and endothelial cellular growthA genetic model provides evidence that the receptor for atrial natriuretic peptide (guanylyl cyclase-A) inhibits cardiac ventricular myocyte hypertrophy.Significance and therapeutic potential of the natriuretic peptides/cGMP/cGMP-dependent protein kinase pathway in vascular regenerationAtrial natriuretic peptides: anticancer agents.Investigation of the association between normal-tension glaucoma and single nucleotide polymorphisms in natriuretic peptide gene.The heart as an endocrine organ.NPR-C: a component of the natriuretic peptide family with implications in human diseases.The role of prostaglandin E2 in endometriosis.Cyclic-GMP-dependent protein kinase inhibits the Ras/Mitogen-activated protein kinase pathway.Cardiac hormones inhibit proliferation of pancreatic cancer but not normal cells.Small cytoplasmic domain peptides of natriuretic peptide receptor-C attenuate cell proliferation through Gialpha protein/MAP kinase/PI3-kinase/AKT pathways.Identification, regulation and anti-proliferative role of the NPR-C receptor in gastric epithelial cells.Novel therapeutic approach for cancer using four cardiovascular hormones.Endothelial production of C-type natriuretic peptide and its marked augmentation by transforming growth factor-beta. Possible existence of "vascular natriuretic peptide system".Peptide receptors in astroglia: focus on angiotensin II and atrial natriuretic peptide.Ten years of natriuretic peptide research: a new dawn for their diagnostic and therapeutic use?Inhibition of atrial natriuretic peptide (ANP) C receptor expression by antisense oligodeoxynucleotides in A10 vascular smooth-muscle cells is associated with attenuation of ANP-C-receptor-mediated inhibition of adenylyl cyclase.Natriuretic peptides inhibit angiotensin II-induced proliferation of rat cardiac fibroblasts by blocking endothelin-1 gene expression.C-type natriuretic peptide regulation of guanosine-3',5'-cyclic monophosphate production in human endothelial cells.Physiological concentration of atrial natriuretic peptide induces endothelial regeneration in vitro.Four peptides decrease the number of human pancreatic adenocarcinoma cells.Atrial natriuretic peptide suppresses the transcription of its guanylyl cyclase-linked receptor.Atrial natriuretic peptide inhibits mitogen-activated protein kinase through the clearance receptor. Potential role in the inhibition of astrocyte proliferation.Cyclic GMP-specific phosphodiesterase 5 regulates growth and apoptosis in pulmonary endothelial cells.Atrial natriuretic peptide-initiated cGMP pathways regulate vasodilator-stimulated phosphoprotein phosphorylation and angiogenesis in vascular endothelium.Contribution of oxidative stress and growth factor receptor transactivation in natriuretic peptide receptor C-mediated attenuation of hyperproliferation of vascular smooth muscle cells from SHR.Natriuretic peptide system gene expression in human coronary arteries.
P2860
Q24515347-178E4A55-1E6C-4941-8F53-3BA8398C5780Q27022988-FC2CBCEF-C28D-4796-A672-15EE76B47D1FQ28082833-5628E8B0-F54C-424A-B2CF-CC29ADF84155Q28240763-A79316ED-2AEA-4B3E-AEE3-054F7F28BBAAQ28362795-1150BF09-2EFD-47FA-AFDE-1D0AD7C8A722Q28573603-993C42D7-4390-41B0-99B8-51CAA2BC9C5BQ28583344-790EC869-E899-406F-8CFA-37C5178801D4Q30382842-3AE89E95-3442-4712-B3E1-771EBC52CF7AQ33920484-47ED13CE-2DC9-4030-9EAD-322C068A334EQ33966980-3A89D21D-3269-40DB-81D4-154CF0FA12ABQ33973358-CCAB8F0E-58A7-4A60-88D5-1F8AFB5707DDQ34051679-2970F440-C82E-42A1-8BB3-BD8F4FC1CBEDQ34207401-078376ED-0729-4FEF-9166-383425E40B7AQ34229552-2B301007-08D1-4C2F-A69C-04235354F338Q34486162-3866FCEF-2A92-4C62-B581-039DA8F5CCECQ34869987-14BF6A94-2B89-4ED6-8F56-9A5DE42A326EQ36317199-174DFD07-FEC3-47B0-AB37-6C573AD06A98Q37069669-E7381BB0-F2B7-48A0-8557-07A9882E83CAQ37703738-7CFEB71E-6020-4FF4-AEE4-374FEC3CDE6EQ37766468-8F96A072-15A4-44AF-A2E0-3F7D18198E63Q37946399-7F011103-4F4F-44F4-AEE2-B982185C49B0Q39576736-78654A2B-CB60-4DED-833E-1463D500C9C5Q39693501-EDCA1F49-A0A9-439B-88EB-E97C56FA4578Q40241686-591AA376-9D0A-4422-95D8-A9EE8970ABC3Q40265174-88D097B9-B48A-4BDB-B899-720CC4D2E5B1Q40506291-1F5D5812-09C3-4594-BD18-4534FF312F30Q40512524-A6AECE97-BEAC-46AF-B80D-6BFDC653DD93Q40633459-2758F1DD-54D8-402F-98E3-DC71F8BAC0F1Q40668654-2735C7F3-002F-4B76-9DB2-704DAAA8AC50Q40891941-5F1EA303-3FD1-442C-80F1-C2C142440C4BQ41951960-63D6A01F-1EC7-4C06-99C4-C1B4E1A1601CQ42466041-94EA87D7-6591-4322-BF70-28F8E837BF3FQ44265336-184008BC-6F99-435B-A2EA-7B5C532B7AAEQ44667860-E794F98D-ACD5-434F-9578-5E01C300393CQ46236975-002482A2-8F09-4676-8B1E-115878041D95Q46274540-57086A9E-275C-4E0D-8397-8F951BFFB5C3Q46406301-68C01223-291A-49BA-939F-8374D9AF3EB9Q46851046-D2361012-4FE1-4440-9DE9-0FA7D1A03EBBQ48173752-5750AF86-1CF7-4227-8EC0-1C24EACB08A9Q48600269-5173B55D-A979-448E-AFAC-5CD1A1713D92
P2860
Atrial natriuretic polypeptide as a novel antigrowth factor of endothelial cells.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh-hant
name
Atrial natriuretic polypeptide as a novel antigrowth factor of endothelial cells.
@en
Atrial natriuretic polypeptide as a novel antigrowth factor of endothelial cells.
@nl
type
label
Atrial natriuretic polypeptide as a novel antigrowth factor of endothelial cells.
@en
Atrial natriuretic polypeptide as a novel antigrowth factor of endothelial cells.
@nl
prefLabel
Atrial natriuretic polypeptide as a novel antigrowth factor of endothelial cells.
@en
Atrial natriuretic polypeptide as a novel antigrowth factor of endothelial cells.
@nl
P2093
P356
P1433
P1476
Atrial natriuretic polypeptide as a novel antigrowth factor of endothelial cells.
@en
P2093
P304
P356
10.1161/01.HYP.19.6.758
P407
P433
P577
1992-06-01T00:00:00Z